e-learning
resources
Vienna 2009
Monday, 14.09.2009
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Change of biochemical parameters of sputum in patients with different types of COPD exaserbation
O. Myronenko, O. Plekhanova, O. Lykholat (Dniepropetrovsk, Dnipropetrovsk, Ukraine)
Source:
Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session:
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session type:
Thematic Poster Session
Number:
2345
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Myronenko, O. Plekhanova, O. Lykholat (Dniepropetrovsk, Dnipropetrovsk, Ukraine). Change of biochemical parameters of sputum in patients with different types of COPD exaserbation. Eur Respir J 2009; 34: Suppl. 53, 2345
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Biochemical parameters of sputum and their correlation with inflammation blood markers in AECOPD patients
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap
Source: Eur Respir J 2014; 43: 421-429
Year: 2013
Comparing sputum rheology and spirometry as pathological markers in respiratory diseases
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Using different pulmonary function parameters for establising reversibility in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 808s
Year: 2006
Relationship of different types of exercise tests to pulmonary function and quality of life in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 68s
Year: 2002
Physiological responses during different clinical exercise protocols in COPD patients
Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment
Year: 2009
Changes in the cellular composition of induced sputum in patients with asthma-COPD overlap
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Some local markers indices of saliva inflammation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004
Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
Comparison of different activity measures in patients with severe COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 68s
Year: 2006
Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Correlations between SGRQ and other clinical and functional parameters in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 809s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept